Trial
NCT03571204
Combination Therapy With 3BNC117 and 10-1074 in HIV-Infected Individuals
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
—
Condition
HIV
Intervention
3BNC117 and 10-1074
Why stopped
Coronavirus 2019 (COVID-19) pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-09